Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Arch Pediatr ; 23(9): 957-62, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27150561

RESUMO

BACKGROUND: Bisphosphonates (BP) are sometimes used in children and young women, but their use requires expertise and caution due to the relative lack of long-term efficacy and safety data. CLINICAL CASES: We report on two dizygotic male twins with a past of mild prematurity who presented at the age of 2 months with moderate clinical craniotabes, hypophosphatemia, normal circulating calcium, severe hypercalciuria, and low parathyroid hormone levels. Following supplementation with oral phosphorus and native vitamin D, the clinical and biological abnormalities disappeared within 2 months. Since the twins were dizygotic and were identical in terms of clinical presentation and progression, the only likely explanation for these transient mineral abnormalities was prenatal or neonatal exposure to a toxic agent. Taking into account their medical past, two drugs were possibly involved: either oral alendronate that their mother had received before pregnancy for misdiagnosed osteoporosis or antireflux medications, or both. DISCUSSION: We believe that these two cases could correspond to the first description of a potential mother-to-fetus transmission of alendronate, inducing early and transient hypophosphatemic rickets, the clinical picture being worsened by the antireflux drugs impairing intestinal phosphate absorption. For pediatric rheumatologists, this raises the question of more clearly defining the indications for BP in female children and teenagers; for rheumatologists, this also demonstrates the importance of correctly diagnosing osteoporosis and not using BP off-label, especially in women of child-bearing age.


Assuntos
Hipercalciúria/induzido quimicamente , Raquitismo Hipofosfatêmico/induzido quimicamente , Alendronato/efeitos adversos , Antiulcerosos/efeitos adversos , Conservadores da Densidade Óssea/efeitos adversos , Esomeprazol/efeitos adversos , Feminino , Humanos , Lactente , Masculino , Hormônio Paratireóideo/sangue , Gravidez , Efeitos Tardios da Exposição Pré-Natal , Gêmeos Dizigóticos
2.
BMJ Case Rep ; 20142014 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-24632898

RESUMO

Adefovir/tenofovir are commonly used antiviral agents in the treatment of chronic hepatitis B infection (CHB). We report a case of CHB-related cirrhosis presenting with sequential femoral neck fractures. Operative reduction and fixation was performed. Laboratory result and imaging was consistent with hypophosphataemic osteomalacia. He had bilateral femoral neck non-union and presented with a new left side subtrochanteric femoral fracture. Corrective osteotomy and cephalomedullary fixation was performed. The fractures healed in 6 months after correction of the hypophosphataemia.


Assuntos
Adenina/análogos & derivados , Antivirais/efeitos adversos , Fraturas do Colo Femoral/cirurgia , Fixação Intramedular de Fraturas , Fraturas não Consolidadas/cirurgia , Organofosfonatos/efeitos adversos , Osteotomia , Raquitismo Hipofosfatêmico/induzido quimicamente , Adenina/efeitos adversos , Fraturas do Colo Femoral/etiologia , Fraturas não Consolidadas/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Raquitismo Hipofosfatêmico/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA